Survivin Inhibition Is Critical for Bcl-2 Inhibitor-Induced Apoptosis in Hepatocellular Carcinoma Cells

Our study aims to study the therapeutic effects of a novel Bcl-2 inhibitor, ABT-263, on hepatocellular carcinoma (HCC) and to provide primary preclinical data for future clinical trial with ABT-263. In this study we showed that Bcl-xL and survivin were up-regulated in HCC cell lines and human liver...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Xiangxuan, Ogunwobi, Olorunseun O., Liu, Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3148218/
https://www.ncbi.nlm.nih.gov/pubmed/21829603
http://dx.doi.org/10.1371/journal.pone.0021980

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3148218/
https://www.ncbi.nlm.nih.gov/pubmed/21829603
http://dx.doi.org/10.1371/journal.pone.0021980

Ejemplares similares